UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D. C., 20549

                                    FORM 10Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                 For the quarterly period ended October 31, 2000

                                       OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
For the transition period from               to
                               -------------    -----------------------

Commission file number 0-20309
                       -------

                          TAPISTRON INTERNATIONAL, INC.
                          -----------------------------
             (Exact name of registrant as specified in its charter)

                  Georgia                                        58-1684918
                  -------                                        ----------
(State or other jurisdiction of incorporation                  (IRS Employer
                  or organization)                           Identification No.)

                              6203 Alabama Highway
                                 P. O. Box 1067
                                Ringgold, Georgia
                                   30736-1067
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (706) 965-9300
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X]  No [   ]

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the most recent practicable date.

          Class                                 Outstanding at  December 1, 2000
- ------------------------------                  --------------------------------
Common Stock $.0004 Par Value                            37,551,494

                                       1



                          TAPISTRON INTERNATIONAL, INC.

                                TABLE OF CONTENTS



PART I   - FINANCIAL INFORMATION

     ITEM 1  - FINANCIAL STATEMENTS

     Condensed Consolidated Balance Sheets at
          July 31, 2000 and October 31, 2000                                   3

     Condensed Consolidated Statements of Operations
         for the Three Months Ended October 31, 1999 and 2000                  5

     Condensed Consolidated Statements of Cash Flows
         for the Three Months Ended October 31, 1999 and 2000                  6

     Notes to Condensed Consolidated Financial Statements                      7

     ITEM 2  - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
     CONDITION AND RESULTS OF OPERATIONS                                       9


PART II  - OTHER INFORMATION

     ITEM 5 - OTHER INFORMATION                                               11

     SIGNATURE                                                                12








                                       2





                          TAPISTRON INTERNATIONAL, INC.
                      CONDENSED CONSOLIDATED BALANCE SHEETS


                                     ASSETS



                                                               Condensed from
                                                             Audited Financial
                                                                 Statements            Unaudited
                                                               July 31, 2000        October 31, 2000
                                                             -----------------      -----------------
                                                                                 
CURRENT ASSETS
   Cash and cash equivalents                                    $   65,812             $   59,323
   Receivables, net of allowance of $25,000                         84,945                 47,823
   Receivables from employees/others                                76,070                 88,262
   Sales contract receivables                                      520,000              1,214,600
   Inventory, net of allowance of $30,000                        3,339,603              2,739,759
   Prepayments                                                      81,107                 83,543
   Deferred income taxes                                           100,000                100,000
                                                                ----------             ----------

            Total current assets                                 4,267,537              4,333,310
                                                                ----------             ----------

PROPERTY AND EQUIPMENT, NET                                        619,641                578,036
                                                                ----------             ----------

OTHER ASSETS
   Long-term receivables, net of allowance of $500,000                  --                     --
   Patents and patent license                                      202,085                201,764
   Deferred income taxes                                         1,800,000              1,800,000
   Other assets                                                      2,500                  2,333
                                                                ----------             ----------

            Total other assets                                   2,004,585              2,004,097
                                                                ----------             ----------

          TOTAL                                                 $6,891,763             $6,915,443
                                                                ==========             ==========




The accompanying notes are an integral part of these financial statements.

                                       3




                          TAPISTRON INTERNATIONAL, INC
                CONDENSED CONSOLIDATED BALANCE SHEETS - CONTINUED



                      LIABILITIES AND STOCKHOLDERS' EQUITY



                                                                    Condensed from
                                                                   Audited Financial
                                                                      Statements               Unaudited
                                                                     July 31, 2000         October 31, 2000
                                                                   -----------------       ----------------
                                                                                      
CURRENT LIABILITIES
   Short-term debt                                                   $  1,750,125           $  2,099,020
   Short-term debt -  related party                                       250,000                225,000
   Current portion of long-term debt                                      200,972                119,064
   Accounts payable                                                       224,998                144,371
   Accrued expenses                                                       269,774                246,265
   Customer deposits                                                       24,095                  5,775
                                                                     ------------           ------------

              Total current liabilities                                 2,719,964              2,839,495
                                                                     ------------           ------------

CONTINGENT REORGANIZATION LIABILITY                                       632,145                     --
                                                                     ------------           ------------

LONG-TERM DEBT                                                                478                     --
                                                                     ------------           ------------

STOCKHOLDERS' EQUITY
   Preferred stock - $.001 par value - 2,000,000
      shares authorized: no shares issued and
      outstanding                                                              --                     --
   Common stock - $.0004 par value - 100,000,000
      shares authorized: 34,841,129 shares issued
      at July 31, 2000 and 38,121,512 as of October 31, 2000               13,936                 15,249
    Additional paid in capital                                         26,357,489             26,988,322
    Accumulated deficit                                               (22,709,223)           (22,804,597)
    Treasury stock - 570,018 shares outstanding at cost                  (123,026)              (123,026)
                                                                     ------------           ------------

              Total stockholders' equity                                3,539,176              4,075,948
                                                                     ------------           ------------

              TOTAL                                                  $  6,891,763           $  6,915,443
                                                                     ============           ============



The accompanying notes are an integral part of these financial statements.


                                       4




                          TAPISTRON INTERNATIONAL, INC.
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                   (UNAUDITED)




                                                               Three Months          Three Months
                                                                   Ended                 Ended
                                                             October 31, 1999      October 31, 2000
                                                             ----------------      ----------------
                                                                               
SALES                                                         $  2,815,805           $  1,719,929

COST OF SALES                                                    1,425,420              1,090,497
                                                              ------------           ------------

      Gross profit                                               1,390,385                629,432

OPERATING EXPENSES                                                 649,831                632,741
                                                              ------------           ------------

OPERATING INCOME (LOSS)                                            740,554                 (3,309)
                                                              ------------           ------------

OTHER INCOME (EXPENSE)
      Interest expense                                             (40,966)               (58,144)
      Interest income                                                    9                     10
      Loss on disposal of asset                                         --                     --
      R&D Experimental & Modifications                                  --                (28,870)
      Gain (Loss) on foreign currency exchange rates               (80,936)                (5,061)
                                                              ------------           ------------

                   Other income (expense)                         (121,893)               (92,065)
                                                              ------------           ------------

Income (Loss) before reorganization items                          618,661                (95,374)

REORGANIZATION ITEMS                                                    --                     --
                                                              ------------           ------------

NET INCOME (LOSS)                                             $    618,661           $    (95,374)
                                                              ============           ============


EARNINGS PER SHARE

Net income (loss)                                                    0.020                 (0.003)

Weighted average number of shares
outstanding                                                     34,785,611             35,364,572



The accompanying notes are an integral part of the financial statements.


                                       5



                          TAPISTRON INTERNATIONAL, INC.
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                  (UNAUDITIED)



                                                                          Three Months          Three Months
                                                                             Ended                 Ended
                                                                        October 31, 1999      October 31, 2000
                                                                        ----------------      ----------------
                                                                                           
CASH FLOWS FROM OPERATING ACTIVITIES:
    Net Income (loss)                                                      $   618,661           $   (95,374)
    Adjustments to reconcile net income (loss) to net
    cash used in operating activities:
         Depreciation and amortization                                          49,959                47,094
         Loss on disposal of asset                                                  --                    --
         Loss on foreign currency exchange rates                                80,936                 5,061
         Changes in operating assets and liabilities:
              (Increase) decrease in receivables                            (1,895,263)             (669,670)
              (Increase) decrease in prepayments                               (69,287)               (2,436)
              (Increase) decrease in inventory                                 362,577               599,844
              Increase (decrease) in accounts payable
                 and accrued expenses                                          122,284              (104,136)
              Increase (decrease) in customer deposits                           7,343               (18,320)
              Increase (decrease) in liabilities subject to
                 settlement under plan of reorganization                            --                    --
                                                                           -----------           -----------
                                                                              (722,790)             (237,937)
                                                                           -----------           -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
    Capital expenditures                                                            --                    --
                                                                           -----------           -----------

              Net cash used in investing activities                                 --                    --
                                                                           -----------           -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
    Proceeds from debt                                                         800,125             1,051,620
    Principal repayment of debt                                               (706,112)             (807,194)
                                                                           -----------           -----------
              Net cash provided by (used in) financing activities               94,013               244,426

NET (DECREASE) IN CASH:                                                       (628,777)               (6,489)
    Cash and cash equivalents - beginning of period                            685,328                65,812
                                                                           -----------           -----------
                                                                           $    56,551           $    59,323
                                                                           ===========           ===========


SUPPLEMENTAL DISCLOSURE OF CASH
    CASH FLOW INFORMATION:
    Cash paid for interest                                                 $    23,154           $    58,144

SUPPLEMENTAL DISCLOSURE OF NONCASH
    INVESTING AND FINANCING ACTIVITIES:
    Issuance of common stock to cover contingent
    reorganization liability                                               $        --           $   632,145



The accompanying notes are an integral part of the financial statements.


                                       6




                          TAPISTRON INTERNATIONAL, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                                OCTOBER 31, 2000

                                   (UNAUDITED)

NOTE 1 - BASIS OF PRESENTATION
- ------------------------------

In the opinion of management of Tapistron International, Inc. ("Tapistron") and
Fabrication Center, Inc. ("FCI"), a wholly-owned subsidiary of Tapistron, the
accompanying unaudited condensed consolidated financial statements contain all
adjustments (consisting of only normal recurring adjustments, except as noted
elsewhere in the notes to the condensed consolidated financial statements)
necessary to present fairly its financial position as of October 31, 2000 and
the results of its operations for the three months ended October 31, 1999 and
2000 and cash flows for the three months ended October 31, 1999 and 2000. These
statements are condensed, and therefore, do not include all of the information
and footnotes required by generally accepted accounting principles for complete
financial statements. The statements should be read in conjunction with the
consolidated financial statements and footnotes included in the Company's Annual
Report on Form 10-K for the year ended July 31, 2000. The results of operations
for the three months ended October 31, 2000 are not necessarily indicative of
the results to be expected for the full year.



NOTE 2 - EARNINGS (NET LOSS) PER SHARE
- --------------------------------------

Earnings (net loss) per share are computed using the weighted average number of
shares of common stock outstanding.


NOTE 3 - INVENTORY
- ------------------

Inventory at October 31, 2000 consists of the following:


Raw Material                              $   773,025
Work in Process                             1,136,769
Finished Goods                                859,965
                                          -----------
                                          $ 2,769,759
Allowance for obsolete inventory              (30,000)
                                          -----------

Total                                     $ 2,739,759
                                          ===========


                                       7



                          TAPISTRON INTERNATIONAL, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



NOTE 4 - CONTINGENT REORGANIZATION LIABILITY
- --------------------------------------------

Under the Amended Plan, the Class 7 unsecured creditors received their pro rata
share of the first $500,000 cash payment and their pro rata share of a second
$500,000 cash payment, payable at $50,000 per new machine sale. With regard to
the balance of their claim, each unsecured creditor could elect either (1) 15%
of the balance of its claim or (2) the creditors pro rata share of 1,000,021
shares of common stock issued by the Company. If between August 29, 1997 and
September 30, 2000, the average of the closing prices of the Company's common
stock for any five (5) consecutive trading day period multiplied by 1,000,021
exceeds the balance of unsecured claims multiplied by factor for time value or
if any unsecured creditor shall sell, pledge, or trade the stock, directly or
indirectly, issued to it, then such creditors shall no longer be entitled to any
further distribution.

July 31, 2000 closing market price                                   $   0.1562
Shares issued to Class 7 (no fractional shares were issued)           1,000,021
                                                                     ----------

Total market value of Class 7 stock                                  $  156,203
                                                                     ----------

Balance of Class 7 unsecured claims                                  $  611,336
Time value factor @8.75%                                             1.28955083
                                                                     ----------

Total liability of Class 7 claims                                    $  788,348
                                                                     ----------

Total contingent liability for stock to cover Class 7 debt           $  632,145
                                                                     ==========

During this quarter, the Company issued common stock to cover the contingent
reorganization liability. The additional shares needed at the determined price
of $0.185 were 3,280,383 shares.











                                       8



                          TAPISTRON INTERNATIONAL, INC.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
- --------------------------------------------------------------------------------


The following discussion and analysis provides information which management
believes is relevant to an assessment and understanding of the Company's
condensed consolidated results of operations and financial condition. The
discussion should be read in conjunction with the condensed consolidated
financial statements and notes thereto.

Results of Operations

Sales
- -----

Revenues for the three months ended October 31, 2000 were $1,719,930 compared
with $2,815,805 for the three months ended October 31, 1999. The decrease in
revenues was due to a decrease in units sold.

Cost of Sales
- -------------

Cost of sales for the three months ended October 31, 2000 were $1,090,497 or 63%
of sales, compared with $1,425,420 or 51% of sales, for the three months ended
October 31, 1999. Units produced for this time period has decreased, which
directly increases total cost of sales. Excess utilization of labor for this
quarter has been used to make the machine operate in a more efficient and
flexible manner. The increased R&D expense will translate into more sales and
less cost per unit.

Operating Expenses
- ------------------

Operating expenses were $632,741 for the three months ended October 31, 2000
compared with $649,831 for the three months ended October 31, 1999. The decrease
in operating expenses was due to substantially less legal expenses during the
three months ended October 31, 2000.

Interest Expense
- ----------------

Interest expense was $58,144 for the three months ended October 31, 2000
compared with $40,966 for the three months ended October 31, 1999. Since
inventory did not turn as fast as the comparable quarter, the short term average
debt was higher for the three months ended October 31, 2000.

Income Tax Expense
- ------------------

The income tax provision is $0 due to utilization of the net operating loss
carry-forward to reduce current taxable income.


                                       9




                         TAPISTRON INTERNATIONAL, INC.,


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS (continued)
- --------------------------------------------------------------------------------

Liquidity and Capital Resources
- -------------------------------

The Company's highly liquid assets (cash and cash equivalents) at October 31,
2000 aggregated $59,322, a decrease from the $65,812 balance at July 31, 2000.
Its working capital position at, October 31, 2000 of $1,494,293, decreased from
the comparable amount of $1,547,573 at July 31, 2000. The decrease in working
capital was mainly a result of increased debt due to the decrease in revenues
for the three months ended October 31, 2000.

Net cash used in operations for the three months ended October 31, 2000 were
$237,937 compared to cash used in operations of $722,790 for the three months
ended October 31, 1999. Net cash used in investing activities totaled $0 for the
three months ended October 31, 2000 compared to $0 used in investing activities
during the three months ended October 31, 1999. Net cash provided by financing
activities was $244,426 during the three months ended October 31, 2000 compared
to cash provided by financing activities of $94,013 during the three months
ended October 31, 1999.

The Company believes its current cash needs will be adequately provided from
anticipated cash generated from operations, short-term borrowings and its lines
of credit. As of October 31, 2000, the Company had available $200,980 on its
lines of credit. Long-term cash requirements, other than normal operating
expenses, depend on the Company's profitability, its ability to manage working
capital requirements, and its rate of growth.

Market Risk
- -----------

A review of the Company's financial instruments and risk exposures at October
31, 2000, revealed that the Company had exposure to foreign currency exchange
rate risks. At October 31, 2000, the Company had an outstanding debt denominated
in the Japanese Yen, which matures in February of 2001. As exchange rates vary,
the Company's financial position, results of operations or cash flows may vary
from expectations and overall expected earnings may be adversely impacted. The
effect of foreign exchange rate fluctuations on the Company during the three
months ending October 31, 2000 was an expense of $5,061.






                                       10




                          TAPISTRON INTERNATIONAL, INC.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS (continued)
- --------------------------------------------------------------------------------

Forward-looking Statements for Purposes of "Safe Harbor" Under the Private
Securities Reform Act of 1995
- ---------------------------------------------------------------------------

The Company has made, and may continue to make, various forward-looking
statements with respect to its financial position, projected costs, projected
savings and plans and objectives of Management.

Such forward-looking statements are identified by the use of forward-looking
words or phrases such as "anticipates," "intends," "expects," "plans,"
"believes," "estimates," or words or phrases of similar import. These
forward-looking statements are subject to numerous assumptions, risks, and
uncertainties, and the statements looking forward beyond October 31, 2000, are
subject to greater uncertainty because of the increased likelihood of changes in
underlying factors and assumptions. Actual results could differ materially from
those anticipated by the forward-looking statements.

The applicable risks and uncertainties include general economic and industry
conditions that affect all international businesses, as well as, matters that
are specific to the Company and the market it serves. Actual sales in Fiscal
2001 may be materially less than the sales projected in the forward-looking
statements if the Company's customers cancel or delay current orders or if the
Company reduces the rate at which it is building or expects to build CYP
machines for such customers. Such cancellations, delays or reductions may occur
if there is a substantial change in the general economy or if a customer were to
experience major financial difficulties. Margins may differ from those projected
in the forward-looking statements if management does not achieve success in
improving margins or other events occur that differ from the estimates used in
preparing the Company's financial statements.

In addition, all subsequent written and oral forward-looking statements
attributable to the Company or person acting on behalf of the Company are
expressly qualified in their entirety by reference to such factors.

The Company's forward-looking statements represent its judgement only on the
dates such statements are made. By making any forward-looking statements, the
Company assumes no duty to update them to reflect new, changed, or unanticipated
events or circumstances.

EXHIBITS AND REPORTS ON FORM 8-K

(a) There are no Exhibits filed with this report.

(b) No reports on Form 8-K were filed during the quarterly period ended
    October 31, 2000.


                                       11



                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized,



                                            Tapistron International, Inc.
                                            -----------------------------
                                            (Registrant)



Date:    December 13, 2000                  /s/Rodney C. Hardeman, Jr.
     ---------------------                  --------------------------
                                            Rodney C. Hardeman, Jr.
                                            (Signing on behalf of the registrant
                                            as President and Chief
                                            Executive Officer)








                                       12